Dow Up 0.36% Nasdaq Up 0.12%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
2.44 Down 0.01(0.41%) 4:00PM EDT
Prev Close:2.45
Open:2.44
Bid:2.14 x 100
Ask:6.43 x 3000
1y Target Est:5.50
Beta:1.28
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.44 - 2.49
52wk Range:2.35 - 5.60
Volume:218,119
Avg Vol (3m):290,038
Market Cap:226.48M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXDown 0.41%226.48M
SHPGDown 0.35%47.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.21
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback